Chief Executive Officer
CoA Therapeutics
Palo Alto California UNITED STATES
Shafique Virani, M.D. is chief executive officer at CoA and CEO in Residence at BridgeBio, LLC. Prior to joining the company, he served as Vice President, Global Head of Neuroscience, Ophthalmology & Rare disease at Roche/Genentech. Shafique brings 13 years of experience in big pharma, and helped build an industry leading portfolio in neuroscience and ophthalmology at Roche through academic collaborations, licensing and acquisitions. Shafique joined Roche in 2004 and served various roles within medical affairs, marketing and business development in the UK, USA and Switzerland until 2012, when he transitioned to the Bay Area. Shafique is trained as a neurosurgeon in Cambridge, UK and Boston, USA and holds the Fellowship of the Royal College of Surgeons of England in addition to an MD from the University of Nottingham.